High caffeine consumption may be associated with an increased risk of breast cancer in women with benign breast disease.
Although high caffeine consumption does not appear to increase the overall risk of breast cancer, it may be associated with an increased risk of breast cancer in women with benign breast disease, and for the development of estrogen receptor-negative and progesterone receptor-negative breast cancer and tumors larger than 2 cm, according to study findings published in the Oct. 13 issue of the Archives of Internal Medicine.
Ken Ishitani, MD, of Brigham and Womens Hospital and Harvard Medical School in Boston, and colleagues studied 38,432 women who were cancer-free in 1992–1995, including 1,188 who developed invasive breast cancer during a mean follow-up of 10 years.
Overall, the researchers found that women who drank at least four cups of coffee or at least two cups of tea per day did not have a higher risk of breast cancer than women who almost never drank these beverages. In women with benign breast disease, they found a borderline significant association between the highest quintile of caffeine consumption and increased risk (RR, 1.32). They also found a positive association between caffeine consumption and the risk of estrogen receptor-negative and progesterone receptor-negative breast cancer and tumors larger than 2 cm (RR, 1.68 and 1.79, respectively).
Ishitani K, Lin J, Manson JE, et al. Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med. 2008;168:2022-2031.
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported
April 19th 2024A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.
Read More